The Promise and the hype of 'personalised medicine'
Personalised medicine is widely considered as the way of the future for medicine. However, progress in cancer, with a few outstanding exceptions, has fallen below expectations because of the challenges of tumour heterogeneity and clonal evolution. In both benign and malignant disease, diseases cause...
Autore principale: | Maughan, T |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Taylor and Francis
2017
|
Documenti analoghi
Documenti analoghi
-
Personalised medicine: the promise, the hype and the pitfalls
di: Feiler, T, et al.
Pubblicazione: (2017) -
Possibilities for personalised medicine in rheumatoid arthritis: hype or hope
di: Pascal Hendrik Pieter de Jong, et al.
Pubblicazione: (2021-11-01) -
Biomarker-guided personalised emergency medicine for all – hope for another hype?
di: Philipp Schuetz, et al.
Pubblicazione: (2015-02-01) -
The threat, hype, and promise of artificial intelligence in education
di: Niklas Humble, et al.
Pubblicazione: (2022-11-01) -
Personalized medicine: hope or hype?
di: Salari, K, et al.
Pubblicazione: (2012)